Sign up for the premium plan and unlock all options
After purchasing the premium plan, you will unlock all information about drug prices and their availability.
Search
Listing 546621 - 546640 out of 553687 entries
| Country | ATC | Drug name | Drug form, strength, package | Price level | Price in € | Price in local currency | Therapeutic areas | Manufacturer / Importer |
|---|---|---|---|---|---|---|---|---|
| USA | (L04AC05) ustekinumab (adm: P) | STELARA 90MG/ML PFS (ULTRA-SAFE) | 1X90MG/1ML | Ex-factory price without vat |
$0-0 |
$0-0 |
Psoriasis;Arthritis, Psoriatic;Crohn Disease;Colitis, Ulcerative | J&JHealthCareSystemsonbehalfofJanssenBiotechInc. |
| USA | (L04AC05) ustekinumab (adm: P) | STEQEYMA 90MG/ML INJ,SYR,1ML | 1ML | Ex-factory price without vat |
$0-0 |
$0-0 |
Psoriasis;Arthritis, Psoriatic;Crohn Disease | CelltrionUSA,Inc. |
| USA | (L04AC05) ustekinumab (adm: P) | YESINTEK 90MG/ML INJ,SYR,1ML | 0.5ML | Ex-factory price without vat |
$0-0 |
$0-0 |
Psoriasis;Arthritis, Psoriatic;Crohn Disease | BioconBiologics,Inc. |
| USA | (L04AC07) tocilizumab (adm: P) | ACTEMRA 200MG/10ML VIAL | 10ML | Ex-factory price without vat |
$0-0 |
$0-0 |
n/a | GenentechUSA,Inc. |
| USA | (L04AC07) tocilizumab (adm: P) | ACTEMRA 200MG/10ML VIAL | 10ML | Ex-factory price without vat |
$0-0 |
$0-0 |
n/a | GenentechUSA,Inc. |
| USA | (L04AC07) tocilizumab (adm: P) | ACTEMRA 400MG/20ML VIAL | 20ML | Ex-factory price without vat |
$0-0 |
$0-0 |
n/a | GenentechUSA,Inc. |
| USA | (L04AC07) tocilizumab (adm: P) | ACTEMRA 400MG/20ML VIAL | 20ML | Ex-factory price without vat |
$0-0 |
$0-0 |
n/a | GenentechUSA,Inc. |
| USA | (L04AC07) tocilizumab (adm: P) | ACTEMRA 80MG/4ML VIAL | 4ML | Ex-factory price without vat |
$0-0 |
$0-0 |
n/a | GenentechUSA,Inc. |
| USA | (L04AC07) tocilizumab (adm: P) | ACTEMRA 80MG/4ML VIAL | 4ML | Ex-factory price without vat |
$0-0 |
$0-0 |
n/a | GenentechUSA,Inc. |
| USA | (L04AC07) tocilizumab (adm: P) | ACTEMRA ACTPEN 162MG/0.9ML INJ,SYRINGE,0.9ML | 0.9ML | Ex-factory price without vat |
$0-0 |
$0-0 |
n/a | GenentechUSA,Inc. |
| USA | (L04AC07) tocilizumab (adm: P) | ACTEMRA ACTPEN 162MG/0.9ML INJ,SYRINGE,0.9ML | 0.9ML | Ex-factory price without vat |
$0-0 |
$0-0 |
n/a | GenentechUSA,Inc. |
| USA | (L04AC07) tocilizumab (adm: P) | ACTEMRA SC 162MG/0.9ML | 0.9ML | Ex-factory price without vat |
$0-0 |
$0-0 |
n/a | GenentechUSA,Inc. |
| USA | (L04AC07) tocilizumab (adm: P) | ACTEMRA SC 162MG/0.9ML | 0.9ML | Ex-factory price without vat |
$0-0 |
$0-0 |
n/a | GenentechUSA,Inc. |
| USA | (L04AC07) tocilizumab (adm: P) | TOCILIZUMAB-AAZG 162MG/0.9ML AUTOINJECTOR | 0.9ML | Ex-factory price without vat |
$0-0 |
$0-0 |
n/a | FreseniusKabi,LLC |
| USA | (L04AC07) tocilizumab (adm: P) | TOCILIZUMAB-AAZG 162MG/0.9ML AUTOINJECTOR | 0.9ML | Ex-factory price without vat |
$0-0 |
$0-0 |
n/a | FreseniusKabi,LLC |
| USA | (L04AC07) tocilizumab (adm: P) | AVTOZMA 20MG/ML INJ,SOLN | 4ML | Ex-factory price without vat |
$0-0 |
$0-0 |
Arthritis, Rheumatoid;Arthritis, Juvenile Rheumatoid;Cytokine Release Syndrome;COVID-19 virus infection | CelltrionUSA,Inc. |
| USA | (L04AC07) tocilizumab (adm: P) | AVTOZMA 20MG/ML INJ,SOLN | 10ML | Ex-factory price without vat |
$0-0 |
$0-0 |
Arthritis, Rheumatoid;Arthritis, Juvenile Rheumatoid;Cytokine Release Syndrome;COVID-19 virus infection | CelltrionUSA,Inc. |
| USA | (L04AC07) tocilizumab (adm: P) | AVTOZMA 20MG/ML INJ,SOLN | 20ML | Ex-factory price without vat |
$0-0 |
$0-0 |
Arthritis, Rheumatoid;Arthritis, Juvenile Rheumatoid;Cytokine Release Syndrome;COVID-19 virus infection | CelltrionUSA,Inc. |
| USA | (L04AC07) tocilizumab (adm: P) | TOFIDENCE 20MG/ML INJ,SOLN,10ML | 10ML | Ex-factory price without vat |
$0-0 |
$0-0 |
Arthritis, Rheumatoid;COVID-19 virus infection;Arthritis, Juvenile Rheumatoid | OrganonLLC |
| USA | (L04AC07) tocilizumab (adm: P) | TOFIDENCE 20MG/ML INJ,SOLN,10ML | 10ML | Ex-factory price without vat |
$0-0 |
$0-0 |
Arthritis, Rheumatoid;COVID-19 virus infection;Arthritis, Juvenile Rheumatoid | OrganonLLC |
Pages
